Navigation Links
A Statement from Nova Oculus Concerning Clinical Trials for AMD in Canada
Date:3/14/2019

ON NOVEMBER 27, 2018, Nova Oculus Partners, LLC, issued a press release announcing that its Canadian partner, the Eye Machine Canada Inc., had been given approval to begin a clinical patient trial in Edmonton, Canada, using Nova Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD).

The previous month, the medical devices bureau of Health Canada had granted an Investigational Testing Authorization for that trial. In making that announcement, the press release also reported that approval of the trial’s protocol and its investigator has been given by the clinical trials committee of the Health Research Ethics Board of Alberta (HREBA).

However, the press release’s assertion that approval of the protocol and the study’s investigator by the clinical trials committee was in error. It was the result of a misunderstanding based on a communication from HREBA that was assumed to be granting such approval. As of today’s date, the Eye Machine Canada Inc. is still awaiting the committee’s approval to proceed with the study.

Nova Oculus Partners, LLC, did not intend to suggest there was approval that at the time it did not believe had actually been granted. Moreover, upon learning of the actual status of the application, Nova Oculus made it clear in subsequent direct communications with its investors that the Eye Machine Canada is still awaiting approval from HREBA of its protocol.

Nova Oculus Partners, LLC, unreservedly apologizes to the members of HREBA, to its clinical trials committee, to the Eye Machine Canada Inc., and to the trial’s investigators for this misunderstanding.

Read the full story at https://www.prweb.com/releases/a_statement_from_nova_oculus_concerning_clinical_trials_for_amd_in_canada/prweb16165557.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Biohaven Files Registration Statement for Proposed Public Offering of its Common Shares
2. BioAmber Issues Statement Required by Section 610(b) of the NYSE MKT Company Guide
3. ASBMT Official Statement Opposing Executive Order on Immigration
4. ASBM Statement on Final Guidance for Industry Nonproprietary Naming of Biological Products
5. Neurotrope Issues Statement On Eli Lillys Solanezumab
6. BIOREM Responds to Statement of Claim
7. Intrexon Expresses Support for Resident Commissioner of Puerto Ricos Statements on Combatting Aedes aegypti Mosquitoes in Puerto Rico and Other U.S. Jurisdictions
8. Lone Star Value Issues Statement To Fellow Enzo Shareholders
9. NW Bio Statement Regarding Appointments
10. NW Bio Issues Statement on Highly Unusual Trading Activity
11. Depomed Issues Statement on Horizon Pharma plcs Unsolicited Exchange Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2019)... ... April 16, 2019 , ... Fulcrum Biometrics , ... that Bank South Pacific (BSP), the largest regionally owned bank in the South ... a contract to deliver a fingerprint-based Know Your Customer (KYC) banking solution that ...
(Date:4/9/2019)... BARBARA, Calif. (PRWEB) , ... April 09, 2019 ... ... professional services firm focused on increasing the capacity of life sciences organizations to ... its Cloud Assurance platform in the past 12 months. , ...
(Date:4/8/2019)... ... 09, 2019 , ... To support the global fight against ... (CZ Biohub) has chosen Geneious Biologics to help them analyze and compare human ... to establish new approaches to inform the discovery of antibody-based diagnostics, new therapies ...
(Date:3/27/2019)... ... ... In honor of National Nutrition Month, Lajollacooks4u has collaborated with the San ... nutrition. This month, Chef Jodi Abel appeared on two segments on KUSI’s Good ... segment addressed the nutritional value of USDA’s MyPlate, a nutrition guide that simplifies the ...
Breaking Biology Technology:
(Date:5/2/2019)... , ... April 30, 2019 , ... ... LLP is pleased to announce that Gunes Bender, Ph.D., a registered patent ... sciences practice group. In his new role, Bender provides technical support and scientific ...
(Date:4/27/2019)... (PRWEB) , ... April 26, ... ... flagship market research study " 2019 Global Assessment Report: The Laboratory Analytical ... product categories is presented in 10 sections that include chromatography, life science ...
(Date:4/25/2019)... ... , ... In recent years the neurocognitive effects of treatments ... cases the magnitude of these deficits and the long-term impact on cognitive maturation ... may impact developmental trajectories, and patients are often so unwell at the time ...
Breaking Biology News(10 mins):